These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 6236381
1. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis]. Scondotto G, De Fabritiis A, Guastarobba A, Amato AC, Filippini M. Minerva Med; 1984 Jul 14; 75(28-29):1733-8. PubMed ID: 6236381 [Abstract] [Full Text] [Related]
2. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study]. Vittoria A, Cappelli R, Messa GL, Auteri A. Minerva Med; 1986 Oct 20; 77(40):1867-72. PubMed ID: 2946002 [No Abstract] [Full Text] [Related]
3. [Therapeutic action of oral mesoglycan in the pharmacologic treatment of the varicose syndrome and its complications]. Petruzzellis V, Velon A. Minerva Med; 1985 Mar 24; 76(12):543-8. PubMed ID: 3157887 [Abstract] [Full Text] [Related]
4. [Results of our experience in the use of mesoglycan in the therapy of acute and chronic venous diseases of the legs]. Mangoni N, Righi D, Lucente E, Tonarelli AP, Lucarelli F, Borgioli F, Nuzzaci G. Minerva Med; 1986 Oct 27; 77(41):1903-8. PubMed ID: 2946983 [No Abstract] [Full Text] [Related]
5. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency. Andreozzi GM. Minerva Cardioangiol; 2007 Dec 27; 55(6):741-53. PubMed ID: 18091643 [Abstract] [Full Text] [Related]
6. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol]. Raso AM, Maggio D, Trogolo M, Rispoli P, Sandrone N, Pezzuto D, Bellan A, Melloni CD. Minerva Cardioangiol; 1997 Dec 27; 45(7-8):383-92. PubMed ID: 9463174 [Abstract] [Full Text] [Related]
7. [Role of mesoglycan in the treatment of venous diseases of surgical importance]. Cianfanelli G, Borreani B, Zepponi E, Brizio L, Colotto P, Toniutti F. Minerva Med; 1986 Oct 27; 77(41):1943-4. PubMed ID: 2946991 [No Abstract] [Full Text] [Related]
8. [Mesoglycan and phlebopathy. A clinico-experimental contribution]. Allegra C, Bonifacio M, Riccioni C, Tonelli V. Minerva Med; 1986 Oct 20; 77(40):1887-92. PubMed ID: 2946005 [No Abstract] [Full Text] [Related]
9. [Treatment of acute and chronic venous pathology of the extremities. Effect of mesoglycan in a case study of 50 patients]. Florio A, Rosati V, Cioffi G. Minerva Med; 1986 Oct 27; 77(41):1933-5. PubMed ID: 2946989 [No Abstract] [Full Text] [Related]
12. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency]. La Marca G, Pumilia G, Martino A. Minerva Cardioangiol; 1999 Sep 27; 47(9):315-9. PubMed ID: 10630070 [Abstract] [Full Text] [Related]
14. Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan. Viliani T, Scarselli M, Pieri A, Gatti M, Santini M, Pasquetti P. Eur J Phys Rehabil Med; 2009 Mar 27; 45(1):21-9. PubMed ID: 19270639 [Abstract] [Full Text] [Related]
17. [Cutaneous clinical and oximetric findings on the activity mesoglycan, administered per os (100 mg/die), in venous dermatitis]. Petruzzellis V, Velon A. Minerva Med; 1986 Oct 27; 77(41):1911-3. PubMed ID: 2946985 [No Abstract] [Full Text] [Related]
18. [Therapeutic activity of oral mesoglycan in venous disease. A clinical and blood coagulation evaluation]. Bracale GC, Selvetella L, Mirabile F, Ruocco A, Varriale V, De Caterina M. Minerva Med; 1986 Oct 27; 77(41):1919-25. PubMed ID: 2946987 [No Abstract] [Full Text] [Related]